2B1A
Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with UG1033 peptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRL BEAMLINE BL11-1 |
Synchrotron site | SSRL |
Beamline | BL11-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2003-02-09 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.98397 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 62.716, 96.890, 97.018 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 31.310 - 2.348 |
R-factor | 0.21287 |
Rwork | 0.211 |
R-free | 0.24446 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2b0s |
RMSD bond length | 0.012 |
RMSD bond angle | 1.328 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | AMoRE |
Refinement software | REFMAC (5.2) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 31.310 | 2.390 |
High resolution limit [Å] | 2.348 | 2.348 |
Number of reflections | 24986 | |
<I/σ(I)> | 31.9 | 2.36 |
Completeness [%] | 98.6 | 92.8 |
Redundancy | 3.7 | 3.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 298 | 13.75% PEG 20000, 0.05M disodium tartrate, VAPOR DIFFUSION, SITTING DROP, temperature 298K |